-+ 0.00%
-+ 0.00%
-+ 0.00%

Urban Edge Properties (UE) Stock Faces Q3 Results And Retail Risk

Simply Wall St·10/28/2026 23:17:21
Listen to the news

Urban Edge Properties shares slipped 1.1% to about US$19 in regular trading on the day of its third quarter 2026 report. That muted reaction came even as funds from operations, the core cash earnings metric for retail real estate investment trusts, reached US$0.38 per share and same property net operating income growth held solid.

Short term traders saw a soft tape and a stock that has fallen roughly 17% over three months. Longer view investors will focus on raised full year FFO guidance and a redevelopment pipeline that could matter far more to multi year returns than today’s small price move.

Like the steady FFO and redevelopment story at Urban Edge Properties but uneasy about a share price that has slipped over the past quarter and muted reactions on earnings day? Compare this setup with stocks on our list of solid balance sheet and fundamentals stocks (24 results).

Q3 2026 Earnings Summary

  • Revenue (Q3 2026 vs. Q3 2025): US$119.6 million vs. US$120.1 million (broadly stable year over year)
  • Net Income (Q3 2026 vs. Q3 2025): US$51.4 million vs. US$14.9 million (strong year over year increase)
  • Basic EPS (Q3 2026 vs. Q3 2025): US$0.41 per share vs. US$0.12 per share (large year over year rise)
  • Funds From Operations (FFO, Q3 2026 vs. Q3 2025): US$51.9 million compared with prior year FFO of US$52.0 million (largely unchanged on a dollar basis)

Earnings only tell part of the story, and investors who care about valuation often anchor on the cash that actually comes through the door. Looking at Urban Edge Properties' cash flows alone, the stock could be a notable 26% undervalued.

NYSE:UE Trailing 12-Month Revenue & Expenses Breakdown as at Oct 2026
NYSE:UE Trailing 12-Month Revenue & Expenses Breakdown as at Oct 2026

Urban Edge bullish thesis: guidance and NOI on trial

"Redevelopment projects and the S&O (signed-not-open) pipeline represent visible, near-term NOI gains (8% of current NOI), while also increasing property values and supporting longer-term revenue and earnings growth."

Urban Edge Properties is putting this claim to work. Same property NOI including redevelopment grew 4.6% in Q3 and 3.6% year to date. Signed but not open rent represents about 7% of annualized NOI with US$2.6m commencing in Q3, another US$0.7m guided for Q4, and roughly US$13m expected in 2027. Management lifted 2026 FFO guidance and targets rent spreads above 30% for the year, which all points to the pipeline starting to earn its keep.

Urban Edge bearish thesis: concentration and tenant risk checked

"Persistent tenant bankruptcies among big box and value-oriented national retailers (such as Big Lots, Party City, At-Home, and concerns regarding Kohl's) highlight an ongoing vulnerability to retail sector disruption and changing consumer preferences, raising the risk of unstable occupancy and greater re-tenanting costs that may pressure net margins and earnings."

This worry meets mixed evidence in the latest figures. Same property lease occupancy sits at 96.6% and shop occupancy at 91.7%. Uncollectible revenue is about 45 bps of gross rent and the bankruptcy watch list is described as smaller than in prior years. Urban Edge Properties sold a Kohl’s anchored center and reports materially lower leasing costs, helped by more as is anchor deals. That points to some insulation so far, even with sector disruption still hanging over big box retail.

One Narrative disagrees with today's price. → See where this Narrative says Urban Edge Properties should trade.

Hunt Quiet Disconnects In Plain View

Urban Edge Properties reports an active quarter and redevelopment pipeline alongside a relatively muted share price reaction. The real opportunity is spotting stocks that could be undervalued before the market closes the gap.

  • Company 1 - 31% below our estimate - tightens execution and adjusts its product mix to lift aftermarket exposure.
  • Company 2 - 25% below our estimate - expands access and manufacturing for incretin medicines as newer drugs form distinct revenue pillars.
  • Company 3 - 40% below our estimate - scales storage, inverter and non tracker offerings so a higher margin mix supports its installed base.

Those are three of them. See the full list of 29 companies trading below our fair value estimates →